FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Bank False Claims Case Can Affect Healthcare Suits

[ Price : $8.95]

Two Epstein Becker Green attorneys write that a False Claims Act case involving a manufacturing firm making allegedly false certif...

GCP Audits Look at Research Quality

[ Price : $8.95]

The FDA Group says that independent Good Clinical Practice audits help ensure that clinical trial subjects rights are respected an...

Bestmed Recalls Faulty Digital Thermometers

[ Price : $8.95]

Bestmed recalls its Digital Temple Thermometer Model No. KD-2201 manufactured by K-Jump Health Co. due to a manufacturing problem ...

Innovative Trial Design Proposal Discussed at PDUFA Meeting

[ Price : $8.95]

A drug industry proposal at a PDUFA negotiation meeting seeks FDA processes to facilitate appropriate use of innovative clinical t...

Repros Gets Complete Response Letter for Enclomiphene

[ Price : $8.95]

FDA sends Repros Therapeutics a complete response letter on an NDA for enclomiphene for treating secondary hypogonadism in overwei...

Lesser-known Preemption Arguments

[ Price : $8.95]

Attorney James Beck reviews three court decisions based on lesser-known preemption arguments.

QS Violations at WalkMed Infusion

[ Price : $8.95]

FDAs Denver District Office warns WalkMed Infusion about Quality System and other violations in its manufacturing of infusion pump...

Objectionable Conditions at Nvision Eye Center

[ Price : $8.95]

FDA warns Nvision Laser Eye Centers about objectionable conditions in its conduct of research on an investigational new drug.

FDA Clears Caputron Medical Brain Stimulator

[ Price : $8.95]

FDA clears a Caputron Medical 510(k) for its mindGear headset for treating depression, insomnia and anxiety.

FDA Approves Baxaltas Adynovate for Hemophilia

[ Price : $8.95]

FDA approves a Baxalta NDA for Adynovate (antihemophilic factor [recombinant], pegylated), an extended circulating half-life recom...